Benefit Of Procalcitonin Guidance In The Management Of Community-Acquired Pneumonia
Share This:
                           

About The Author

Thomas Walsh M.D. is a doctor and researcher affiliated with the Allegheny Health Network. His research focus is in infectious and microbial diseases.

                       

Benefit Of Procalcitonin Guidance In The Management Of Community-Acquired Pneumonia

Community-acquired pneumonia (CAP) is one of the leading causes of hospitalization in the United States, with 6 cases per 1000 persons per year. More than 900,000 episodes per year occur in adults aged 65 years and older. CAP is also one of the leading causes of death with more than 60,000 deaths in the United States per year. Nearly 1 in 4 persons who are hospitalized due to CAP die within the subsequent 30 days. The annual direct medical costs...

Read more